Related Experiment Video
Updated: Jul 18, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
[Statin induced neuropathy: myth or reality?]
1Service ENMG et Pathologies Neuromusculaires, Hôpital Neurologique, Bron. christophe.vial@chu-lyon.fr
Revue Neurologique
|December 8, 2006
Summary
Statins, commonly prescribed for cardiovascular health, show minimal toxicity to peripheral nerves. Careful patient selection and monitoring are essential when prescribing these lipid-lowering drugs.
Area of Science:
- Pharmacology
- Neuroscience
- Cardiovascular Medicine
Context:
- Statins are widely used lipid-lowering drugs for cardiovascular disease prevention.
- Concerns exist regarding potential toxic effects of statins on the peripheral nervous system.
- Existing evidence includes case reports, retrospective studies, and a single prospective study.
Purpose:
- To evaluate the potential neurotoxic effects of statins on the peripheral nervous system.
- To synthesize current understanding of statin-induced peripheral neuropathy.
- To inform clinical practice regarding statin prescription and patient monitoring.
Summary:
- Statins, inhibitors of HMGCoA reductase, lower lipids but may affect nerve function.
- Mechanisms include interference with cholesterol synthesis impacting myelin and nerve membranes.
- Mitochondrial energy use may also be disturbed by statin-induced changes in enzyme synthesis.
- Evidence suggests statins have insignificant toxicity on peripheral nerves.
Impact:
- Highlights the need for careful evaluation of statin prescription relevance.
- Emphasizes the importance of close patient monitoring for potential side effects.
- Contributes to informed clinical decision-making in cardiovascular pharmacotherapy.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...